FDA Revises Prescriber DTC Survey To Focus On Patient Interactions
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency appeared unusually receptive to outside suggestions about a proposed questionnaire, dropping questions related to drug pricing and adding ones about exam room conversations.
You may also be interested in...
DTC Rx Drug Ad Study No. 30: Do Market Claims Impact Perception?
FDA to assess whether claims such as '#1 prescribed' affect consumer views of drug product; project to cost $529,742. Chart notes price tag for 18 other DTC studies.
FDA’s Biggest DTC Advertising Study Eyes Online Promotion
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
FDA’s Social Media Guidance: As Industry Waits, How Watchful Should It Be?
In the absence of clear policy from the agency, GSK keeps careful eyes on Facebook, but experts disagree on the extent to which drug companies are required to actively monitor social media sites.